525 related articles for article (PubMed ID: 19139168)
1. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.
Cruz-Guilloty F; Pipkin ME; Djuretic IM; Levanon D; Lotem J; Lichtenheld MG; Groner Y; Rao A
J Exp Med; 2009 Jan; 206(1):51-9. PubMed ID: 19139168
[TBL] [Abstract][Full Text] [Related]
2. Notch regulates cytolytic effector function in CD8+ T cells.
Cho OH; Shin HM; Miele L; Golde TE; Fauq A; Minter LM; Osborne BA
J Immunol; 2009 Mar; 182(6):3380-9. PubMed ID: 19265115
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cell Group 7 Sequence in Cytotoxic Cells Optimizes Exocytosis of Lytic Granules Essential for the Perforin-Dependent, but Not Fas Ligand-Dependent, Cytolytic Pathway.
Morikawa Y; Murakami M; Kondo H; Nemoto N; Iwabuchi K; Eshima K
Immunohorizons; 2021 Apr; 5(4):234-245. PubMed ID: 33911019
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.
Eshima K; Chiba S; Suzuki H; Kokubo K; Kobayashi H; Iizuka M; Iwabuchi K; Shinohara N
Immunol Lett; 2012 May; 144(1-2):7-15. PubMed ID: 22425747
[TBL] [Abstract][Full Text] [Related]
5. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
6. Complex Interplay Between MAZR and Runx3 Regulates the Generation of Cytotoxic T Lymphocyte and Memory T Cells.
Gülich AF; Rica R; Tizian C; Viczenczova C; Khamina K; Faux T; Hainberger D; Penz T; Bosselut R; Bock C; Laiho A; Elo LL; Bergthaler A; Ellmeier W; Sakaguchi S
Front Immunol; 2021; 12():535039. PubMed ID: 33815354
[TBL] [Abstract][Full Text] [Related]
7. Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells.
Smith C; Elhassen D; Gras S; Wynn KK; Dasari V; Tellam J; Tey SK; Rehan S; Liu YC; Rossjohn J; Burrows SR; Khanna R
Blood; 2012 Oct; 120(16):3237-45. PubMed ID: 22942184
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.
Pipkin ME; Sacks JA; Cruz-Guilloty F; Lichtenheld MG; Bevan MJ; Rao A
Immunity; 2010 Jan; 32(1):79-90. PubMed ID: 20096607
[TBL] [Abstract][Full Text] [Related]
10. Control of effector CD8+ T cell function by the transcription factor Eomesodermin.
Pearce EL; Mullen AC; Martins GA; Krawczyk CM; Hutchins AS; Zediak VP; Banica M; DiCioccio CB; Gross DA; Mao CA; Shen H; Cereb N; Yang SY; Lindsten T; Rossant J; Hunter CA; Reiner SL
Science; 2003 Nov; 302(5647):1041-3. PubMed ID: 14605368
[TBL] [Abstract][Full Text] [Related]
11. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
[TBL] [Abstract][Full Text] [Related]
12. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells.
Brown DM; Kamperschroer C; Dilzer AM; Roberts DM; Swain SL
Cell Immunol; 2009; 257(1-2):69-79. PubMed ID: 19338979
[TBL] [Abstract][Full Text] [Related]
13. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
14. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
15. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet.
Sutherland AP; Joller N; Michaud M; Liu SM; Kuchroo VK; Grusby MJ
J Immunol; 2013 Apr; 190(8):3977-84. PubMed ID: 23479229
[TBL] [Abstract][Full Text] [Related]
16. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.
Sin JI; Kim JM; Bae SH; Lee IH; Park JS; Ryoo HM
Mol Ther; 2009 May; 17(5):906-13. PubMed ID: 19277009
[TBL] [Abstract][Full Text] [Related]
18. Eomes cannot replace its paralog T-bet during expansion and differentiation of CD8 effector T cells.
Fixemer J; Hummel JF; Arnold F; Klose CSN; Hofherr A; Weissert K; Kögl T; Köttgen M; Arnold SJ; Aichele P; Tanriver Y
PLoS Pathog; 2020 Sep; 16(9):e1008870. PubMed ID: 32991634
[TBL] [Abstract][Full Text] [Related]
19. CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin.
Hegel JK; Knieke K; Kolar P; Reiner SL; Brunner-Weinzierl MC
Eur J Immunol; 2009 Mar; 39(3):883-93. PubMed ID: 19224637
[TBL] [Abstract][Full Text] [Related]
20. The Transcription Factor Runx3 Establishes Chromatin Accessibility of cis-Regulatory Landscapes that Drive Memory Cytotoxic T Lymphocyte Formation.
Wang D; Diao H; Getzler AJ; Rogal W; Frederick MA; Milner J; Yu B; Crotty S; Goldrath AW; Pipkin ME
Immunity; 2018 Apr; 48(4):659-674.e6. PubMed ID: 29669249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
